Lithium Ion

Lithium Ion

SCHEMBL7034022

COc1ccc(C(=O)Nc2ccc(-c3cccc4cccnc34)cc2C(=O)[O-])cc1.[Li+]

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.64
SERPINE1 P05121 1/20 0.64
KMT2A Q03164 5/20 0.58
ENPP1 P22413 1/20 0.51
MEN1 O00255 3/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 6/20 0.49
KDM4E B2RXH2 3/20 0.49
LMNA P02545 2/20 0.49
HPGD P15428 2/20 0.49
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
ALDH1A1 P00352 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
HTT P42858 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7040328 0.90 KMT2A (0.60) PPARGSERPINE1KMT2AENPP1MEN1
SCHEMBL7036040 0.90 KMT2A (0.60) PPARGSERPINE1KMT2AENPP1MEN1
SCHEMBL7034025 0.90 KMT2A (0.59) PPARGSERPINE1KMT2AENPP1MEN1
SCHEMBL417230 0.82 SERPINE1 (0.83) PPARGSERPINE1KMT2AENPP1MEN1
Lithium Ion SCHEMBL7038167 0.82 PPARG (0.65) PPARGSERPINE1KMT2AENPP1MEN1
SCHEMBL19748126 0.78 KMT2A (0.77) KMT2AMEN1POLBMAPTKDM4E
SCHEMBL30063285 0.78 KMT2A (0.77) KMT2AMEN1POLBMAPTKDM4E
SCHEMBL420754 0.78 SERPINE1 (1.00) PPARGSERPINE1KMT2AMEN1MAPT
SCHEMBL29896767 0.78 SERPINE1 (1.00) PPARGSERPINE1KMT2AMEN1MAPT
SCHEMBL422357 0.78 SERPINE1 (0.64) PPARGSERPINE1KMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073862-A1 Compounds BIOVITRUM AB (SE) 2003-04-17 US disclosed
WO-2003004458-A1 NEW COMPOUNDS BIOVITRUM AB (SE) 2003-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073862-A1 Compounds PPARG, PPARA, PPARD PPARG 1/4885SERPINE1 1107/4885KMT2A 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.